TFChem, the French subsidiary of Vancouver-based Sirona Biochem Corp, has received a $1.2 million, no-interest loan from Bpifrance (France's public investment bank) and the District of Haute Normandie. The funding will be used to move the subsidiary's anti-aging compounds into preclinical testing with repayment slated to commence in late 2018. The loan reduces Sirona's financing requirements and will allow the firm to test its anti-aging compounds without dilution. Sirona is a cosmetic ingredient and drug development company with a proprietary technology platform developed at its French facilities. The anti-aging market is currently valued at US$220 billion annually….